1. Home
  2. MDGL vs JXN Comparison

MDGL vs JXN Comparison

Compare MDGL & JXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • JXN
  • Stock Information
  • Founded
  • MDGL 2011
  • JXN 1961
  • Country
  • MDGL United States
  • JXN United States
  • Employees
  • MDGL N/A
  • JXN N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • JXN Life Insurance
  • Sector
  • MDGL Health Care
  • JXN Finance
  • Exchange
  • MDGL Nasdaq
  • JXN Nasdaq
  • Market Cap
  • MDGL 6.1B
  • JXN 6.0B
  • IPO Year
  • MDGL N/A
  • JXN N/A
  • Fundamental
  • Price
  • MDGL $314.31
  • JXN $87.61
  • Analyst Decision
  • MDGL Strong Buy
  • JXN Hold
  • Analyst Count
  • MDGL 9
  • JXN 5
  • Target Price
  • MDGL $420.63
  • JXN $96.40
  • AVG Volume (30 Days)
  • MDGL 282.4K
  • JXN 670.0K
  • Earning Date
  • MDGL 08-06-2025
  • JXN 08-06-2025
  • Dividend Yield
  • MDGL N/A
  • JXN 3.68%
  • EPS Growth
  • MDGL N/A
  • JXN N/A
  • EPS
  • MDGL N/A
  • JXN 1.09
  • Revenue
  • MDGL $317,383,000.00
  • JXN $7,422,000,000.00
  • Revenue This Year
  • MDGL $286.17
  • JXN $114.12
  • Revenue Next Year
  • MDGL $64.17
  • JXN $2.02
  • P/E Ratio
  • MDGL N/A
  • JXN $79.57
  • Revenue Growth
  • MDGL N/A
  • JXN 110.55
  • 52 Week Low
  • MDGL $200.63
  • JXN $64.70
  • 52 Week High
  • MDGL $377.46
  • JXN $115.22
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 64.53
  • JXN 53.22
  • Support Level
  • MDGL $284.02
  • JXN $85.28
  • Resistance Level
  • MDGL $311.21
  • JXN $90.95
  • Average True Range (ATR)
  • MDGL 11.94
  • JXN 2.04
  • MACD
  • MDGL 2.74
  • JXN -0.18
  • Stochastic Oscillator
  • MDGL 100.00
  • JXN 56.71

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About JXN Jackson Financial Inc.

Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.

Share on Social Networks: